| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 295.626 | 87 |
| GSM780708 | Untreated after 4 days (C2_1) | 271.799 | 87 |
| GSM780709 | Untreated after 4 days (C3_1) | 209.559 | 84 |
| GSM780719 | Untreated after 4 days (C1_2) | 317.881 | 88 |
| GSM780720 | Untreated after 4 days (C2_2) | 291.137 | 87 |
| GSM780721 | Untreated after 4 days (C3_2) | 254.233 | 86 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 266.262 | 86 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 288.726 | 87 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 299.546 | 87 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 269.484 | 86 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 293.478 | 87 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 337.067 | 88 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 298.863 | 87 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 281.124 | 87 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 272.823 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 289.106 | 87 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 286.116 | 87 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 303.435 | 87 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 327.898 | 88 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 289.75 | 87 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 315.427 | 88 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 316.164 | 88 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 299.396 | 87 |